Rift Valley fever vaccine trials will soon begin, giving hope that a vaccine will be released in the next five years.
The Coalition for Epidemic Preparedness Innovations (CEPI), which has been working on the inoculation, says trials will take three to four years. Rift Valley fever vaccine trials, CEPI project leader Mike Whelan said this week that 17 vaccine candidates have been selected to undergo trials for the vaccine, but will first go through pre-clinical stages to determine their suitability. “We estimate that the initial trial projects will likely take three to four years to complete,” Mr Whelan said. “After that, depending on available data, successful vaccines will move forward into efficacy trials before a licence for human use can be granted,” he added. The efficacy trials will determine whether people in the clinical trial who got vaccinated with the Rift Valley fever vaccine are less likely to develop the disease than those who got the placebo shot.
Source: This news is originally published by theeastafrican